US 10683503
Antisense oligomers for treatment of conditions and diseases
granted A61KA61K9/0019A61K9/0085
Quick answer
US patent 10683503 (Antisense oligomers for treatment of conditions and diseases) held by STOKE THERAPEUTICS, INC. expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- STOKE THERAPEUTICS, INC.
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61K, A61K9/0019, A61K9/0085, A61P, A61P25/00